Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study
- 22 January 2020
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 57 (5) , 2167-2178
Abstract
An imbalance of inflammatory/anti-inflammatory and oxidant/antioxidant molecules has been implicated in the demyelination and axonal damage in multiple sclerosis (MS). The current study aimed to evaluate the plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptor (sTNFR)1, sTNFR2, adiponectin, hydroperoxides, advanced oxidation protein products (AOPP), nitric oxide metabolites, total plasma antioxidant capacity using the total radical-trapping antioxidant parameter (TRAP), sulfhydryl (SH) groups, as well as serum levels of zinc in 174 MS patients and 182 controls. The results show that MS is characterized by lowered levels of zinc, adiponectin, TRAP, and SH groups and increased levels of AOPP. MS was best predicted by a combination of lowered levels of zinc, adiponectin, TRAP, and SH groups yielding an area under the receiver operating characteristic (AUC/ROC) curve of 0.986 (±0.005). The combination of these four antioxidants with sTNFR2 showed an AUC/ROC of 0.997 and TRAP, adiponectin, and zinc are the most important biomarkers for MS diagnosis followed at a distance by sTNFR2. Support vector machine with tenfold validation performed on the four antioxidants showed a training accuracy of 92.9% and a validation accuracy of 90.6%. The results indicate that lowered levels of those four antioxidants are associated with MS and that these antioxidants are more important biomarkers of MS than TNF-α signaling and nitro-oxidative biomarkers. Adiponectin, TRAP, SH groups, zinc, and sTNFR2 play a role in the pathophysiology of MS, and a combination of these biomarkers is useful for predicting MS with high sensitivity, specificity, and accuracy. Drugs that increase the antioxidant capacity may offer novel therapeutic opportunities for MS.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001.)
This publication has 58 references indexed in Scilit:
- Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the diseaseMolecular Medicine Reports, 2013
- Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scaleJournal of the Neurological Sciences, 2012
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Serum Adiponectin, TNF-α, IL-12p70, and IL-13 Levels in Multiple Sclerosis and the Effects of Different Therapy RegimensNeuroimmunomodulation, 2010
- TNF receptor 2 pathway: drug target for autoimmune diseasesNature Reviews Drug Discovery, 2010
- Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co‐twin studyEuropean Journal of Neurology, 2010
- Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDLBiochemical and Biophysical Research Communications, 2004
- Novel Modulator for Endothelial Adhesion MoleculesCirculation, 1999
- Oxidative stress in blood of HIV infected patientsClinica Chimica Acta, 1996
- Hydroperoxide-initiated chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscleFree Radical Biology and Medicine, 1991